gabexate - CISMeF

Preferred Label : gabexate;

MeSH definition : A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.;

CISMeF synonym : 102391-46-8 (Gabexate methanesulfonate);

MeSH hyponym : gabexate monomethanesulfonate, 14C-Labeled cpd; foy; gabexate monomethanesulfonate; gabexate methanesulfonate; Gabexate Monomethanesulfonate, 14C Labeled Cpd; Monomethanesulfonate, Gabexate; Methanesulfonate, Gabexate; Gabexate Mesylate; Mesylate, Gabexate; Gabexate Mesilate; Mesilate, Gabexate;

MeSH CAS label : benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester;

MeSH Related Number : gabexate monomethanesulfonate, 14C-Labeled cpd; gabexate monomethanesulfonate; gabexate methanesulfonate; 102391-46-8 (methanesulfonate); 39492-01-8 (Gabexate); 56974-48-2 (monomethanesulfonate(14C-labeled cpd)); 56974-61-9 (monomethanesulfonate); E3Q07L0649;

Registry Number MeSH : 39492-01-8;

Related CAS MeSH : 56974-48-2 (Gabexate monomethanesulfonate, 14C-Labeled cpd); 56974-61-9 (Gabexate monomethanesulfonate); E3Q07L0649 (Gabexate methanesulfonate);

Wikipedia link : https://en.wikipedia.org/wiki/Gabexate;

Is substance : O;

UNII : 4V7M9137X9;

InChIKey : YKGYIDJEEQRWQH-UHFFFAOYSA-N;

Details

Origin ID

D016670;

UMLS CUI

C0085231;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Gabexate [NCIt concept]
Pharmacological action(s)
- anticoagulants [MeSH Descriptor]
- serine proteinase inhibitors [MeSH Descriptor]
Record concept(s)
- foy [MeSH concept]
- gabexate [MeSH concept]
- gabexate methanesulfonate [MeSH concept]
- gabexate monomethanesulfonate [MeSH concept]
- gabexate monomethanesulfonate, 14C-Labeled cpd [MeSH concept]
Related MeSH Supplementary Concept(s)
- camostat [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Gabexate [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients